Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
Looking for participantsN/A

Hypertension Explored in Long-term Postpartum Follow-up in Later Life

Sponsor: University of Oxford

NCT ID: NCT06187012

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Health checks and monitoring — no treatment given
Type of study
Observational (no treatment given)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
Hypertensive pregnancy (other)
How long the study runs
Study runs about 236 months (dates as stated)
About the drug or intervention
Hypertensive pregnancy — other: Participants will attend one visit lasting approximately 3-4 hours on a single day or split over multiple visits to complete all measures.
Patient visit burden
Not specified by the sponsor
Type of study
Observing health over time
Ages
30 Years to 70 Years
Who
Female
Number of participants
200
Started
2023-03-23
Last checked
2026-04

Plain English Summary

What is this study?

  • • Testing a new treatment for hypertension
  • • Clinical study - 200 participants
  • • The purpose of this study is to understand more about why women who have had hypertensive pregnancies may be at increased risk of high blood pressure and why these women are often at increased risk of heart and blood vessel disease later in life

Who can take part?

  • • Ages 30 Years to 70 Years
  • • Diagnosed with hypertension
  • • Female only

Where?

  • • Oxford - University of Oxford Department of Cardiovascular Medicine

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

The purpose of this study is to understand more about why women who have had hypertensive pregnancies may be at increased risk of high blood pressure and why these women are often at increased risk of heart and blood vessel disease later in life.

More detail

Women who experience high blood pressure during pregnancy are at increased risk of developing cardiac and vascular diseases later in life. They show changes in their heart, brain, and blood vessels long before they develop high blood pressure. The investigators therefore think that these changes develop slowly over the course of the life of the woman and establish their risk of later disease. Through better understanding of the pattern of changes across multiple parts of the body over extended periods of time, the investigators aim to identify how advanced the underlying disease is for an individual and how the disease is likely to develop over the next few years. By comparing the rate of change across different parts of the body, the investigators can examine how one area affects another. Data including images of the heart, brain and blood vessels will be acquired in women 10 to 25 years after their pregnancy. The initial analysis will focus on assessing differences between women who have had a normotensive pregnancy and those who have had a hypertensive pregnancy, both at a single timepoint and in changes within individuals over time. This dataset will then be used in conjunction with previously acquired data in women who have experienced a hypertensive pregnancy to find out how patterns emerge across the whole body. The investigators will subsequently combine information from different measures at the same time and use the machine learning models to learn the patterns of change that occur as a person progresses from a healthy to a diseased state. This will allow the researchers to identify patterns of hypertensive disease development and it may open doors to better interventions and therapies tailored towards individuals.

HypertensionCardiovascular DiseasesCerebrovascular DisordersVascular Diseases

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 30 Years - 70 Years
  • Who can join: Female only

What the study is looking for

  • ✓Inclusion Criteria
  • ✓Participant is willing and able to give agreement to take part for participation in the study
  • ✓Female who had a pregnancy 10 to 25 years prior
  • ✓Able (in the investigator's opinion) and willing to comply with all study requirements.
  • ✓Adequate understanding of verbal and written English

Who cannot take part

  • ✗The participant may not enter the study if ANY of the following apply:
  • ✗Over 10 weeks pregnant during the course of the study
  • ✗Evidence of congenital heart disease or significant chronic disease relevant to cardiovascular or metabolic status
  • ✗Any significant disease or disorder which, in the opinion of the investigator, might influence the participant's...
  • ✗For exclusion of MRI component only:
See the full criteria
Inclusion Criteria: * Inclusion Criteria * Participant is willing and able to give informed consent for participation in the study * Female who had a pregnancy 10 to 25 years prior * Able (in the investigator's opinion) and willing to comply with all study requirements. * Adequate understanding of verbal and written English Exclusion Criteria: * The participant may not enter the study if ANY of the following apply: * Over 10 weeks pregnant during the course of the study * Evidence of congenital heart disease or significant chronic disease relevant to cardiovascular or metabolic status * Any significant disease or disorder which, in the opinion of the investigator, might influence the participant's ability to participate in the study For exclusion of MRI component only: • Unsuitable for MRI based on the responses to the MRI screening form. The participant may still be included in other parts of the study.

Where Is This Study? (1 UK site)

University of Oxford Department of Cardiovascular Medicine

Oxford OX3 9DU, United Kingdom

Recruiting
Site contact (verified)
Paul Leeson, PhD MRCP FESCPrincipal Investigator

How to Get in Touch

Katie Suriano

Sponsor contact

CONTACT

01865226845 helpful@cardiov.ox.ac.uk
Data sourced from ClinicalTrials.gov · Last verified: 2026-04